Alphyn Biologics
Latest round
- Series B
Last raised
- Dec 2025
Total raised
- $28M
Investors
- 3
About Alphyn Biologics
Based in Maryland, US, and founded in 2019 by Neal Koller (CEO), Alphyn Biologics, Inc. Fka Alphyn Biologics, LLC, operates as a dermatology company that improves people's lives by curing the most difficult, severe skin diseases. Alphyn Biologics created a product called AB-101's that offers numerous benefits such as pre-clinical testing requirements, animal testing requirements, moving directly to Phase 2 human clinical trials, and so on. The AB-101 platform biomaterial will be used to target the most difficult, severe, and prevalent skin diseases confronting humanity. Furthermore, atopic dermatitis is AB-101's first target disease (or AD, also known as Eczema). The company generates revenue through licensing, partnerships, and milestone payments for dermatology therapeutics.
Who invested in Alphyn Biologics
3 investors across 2 rounds
See all investors in Alphyn Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alphyn Biologics
Who invested in Alphyn Biologics?
Alphyn Biologics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alphyn Biologics raised?
Alphyn Biologics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Alphyn Biologics last raise money?
Alphyn Biologics's most recent round on record is a Series B, in Dec 2025.
What does Alphyn Biologics do?
Based in Maryland, US, and founded in 2019 by Neal Koller (CEO), Alphyn Biologics, Inc.
Where is Alphyn Biologics headquartered?
Alphyn Biologics is headquartered in Annapolis, US.
Which VCs invest in companies like Alphyn Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alphyn Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Alphyn Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.